AVEO Pharmaceuticals
$0.9859876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.985
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.0322 (-3.25%) Today
+$0.0272 (2.84%) As of 5:14 PM EDT after-hours
Why Robinhood?
You can buy or sell AVEO and other stocks, options, ETFs, and crypto commission-free!
About AVEO
AVEO Pharmaceuticals, Inc. Common Stock, also called AVEO Pharmaceuticals, is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Read More Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.
Employees
17
Headquarters
Cambridge, Massachusetts
Founded
2001
Market Cap
159.14M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
7.30M
High Today
$1.01
Low Today
$0.9501
Open Price
$1.00
Volume
951.87K
52 Week High
$3.59
52 Week Low
$0.4906
Collections
Price Paid on Robinhood
32% Lower
Right Now
52 Week Low
$0.4906
Average Price Paid
$1.45
52 Week High
$3.59
AVEO Earnings
-$0.18
-$0.13
-$0.07
-$0.02
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 8, Pre-Market